Pharmaceuticals, Biotechnology and Life Sciences
New analyses of microperimetry data showed positive trends with both monthly and every-other-month pegcetacoplan treatment near the GA lesion border…
CAMBRIDGE, Mass., Sept. 30, 2022 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a diversified oncology company focused on developing…
– New data highlight that a single intravitreal injection of Ixo-vec can lead to stable and persistent aflibercept expression through…
Conference Call and Webcast Set for 8:30 a.m. EDTSALT LAKE CITY, Sept. 30, 2022 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN)…
– SNS-101 demonstrated a favorable pharmacokinetic profile, enhanced anti-tumor effects in combination with anti-PD-1 antibodies and a significantly improved cytokine…
Company announcement – No. 42 / 2022 Total number of shares and voting rights in Zealand Pharma at September 30, 2022…
Medexus’s borrowing capacity under its revolving credit facility increases byUS$5.0 million, from US$20.0 million to US$25.0 million Transaction strengthens Medexus’s balance sheet, providing…
LAWRENCEVILLE, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) — Imunon, Inc. (NASDAQ: IMNN), a clinical-stage drug development company focused on DNA-based immunotherapy…
Lille (France), Cambridge (Massachusetts, United States), September 29, 2022 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated…
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing…